Portfolio company
Neurotrack
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Altoida
This company develops an augmented reality platform to assess cognitive function and detect Alzheimer's disease for healthcare providers and clinical researchers.
Neurovision
This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.
MindAhead
This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
Cogstate
This company provides digital cognitive assessments and clinical trial services for biopharmaceutical companies, academic researchers and healthcare providers to measure brain health.
Neu Health
This company develops a digital neurology platform for Parkinson's disease and dementia patients and clinicians to monitor symptoms and manage care remotely.
Mindmore
This company provides a digital platform for automated cognitive testing to healthcare clinics and patients with conditions affecting brain function.
COGNITIVE ASSESSMENT & CARE
This digital health platform provides cognitive screening, assessment and care planning software for healthcare providers to manage patients with cognitive impairment or dementia.
